NCT03268811 - A Study in Japanese Children With Short Bowel Syndrome Who Completed SHP633-302 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 23, 2017

Primary Completion Date

November 2, 2021

Study Completion Date

November 2, 2021

Conditions

Short Bowel Syndrome

Interventions

DRUG

Teduglutide

Teduglutide 0.05 mg/kg SC injection will be administered once daily into 1 of the 4 quadrants of the abdomen or either thigh or arm.

Trial Locations (6)

Akita University Hospital, Akita

Kyushu University Hospital, Fukuoka

Tsukuba University Hospital, Tsukuba

Kagoshima University Hospital, Kagoshima

Tohoku University Hospital, Sendai

Showa University Hospital, Shinagawa-ku